Mr. Sutherland founded Canine Biologics in 2019. He has an extensive background in marketing, management and information systems through his 30+ years of employment with major U.S. and international advertising, technology and consulting organizations. Mr. Sutherland also enjoys recent, significant experience in the pet food category.

Dr. Safavi previously was the founder of BioAgilytix Labs. He is a veteran biochemist who has extensive experience in establishing and leading bioanalytical teams in support of the development of biological products in preclinical and clinical-trial laboratories in pharmaceutical, biotechnology, manufacturing companies and contract research organizations

Mr. Mueller is a former CFO for three companies specializing in manufacturing, software and the oil and gas industry, all with sales in excess of $200 million per annum.

Ms. Brauns is a sales, marketing and media executive with more than 30 years of business experience. She founded Mile High Dog magazine in 2007 where she was editor-in-chief and vice president of sales and marketing. With extensive knowledge of canine health and wellness, and a life-long passion for animal welfare, Ms. Brauns joined Canine Biologics to help improve the lives of dogs fighting cancer. Prior to working in the pet industry, she held executive sales and marketing positions in the real estate and high-tech industries.

Dr. David Haworth is the president and co-founder of Vidium Animal Health. David’s 20+ years in the animal health industry include being president of PetSmart Charities in the US and Canada, and before that the CEO of Morris Animal Foundation. He spent time as a Director of Global Alliances and a Director of Research and Development at Pfizer Animal Health (now Zoetis). He holds DVM and PhD degrees from Colorado State University and completed a postdoctoral fellowship at Colorado State University’s Flint Cancer Center. David’s Labrador Retriever, Bridger is a cancer survivor and enjoys swimming, chasing birds, barking at the mailman and long walks with his dad.

Dr. Korinn Saker is an associate professor of clinical nutrition at the College of Veterinary Medicine at North Carolina State University and a Diplomate of the American College of Veterinary Nutrition. She obtained her DVM from the University of Georgia, Athens and her PhD in Veterinary Medical Sciences from the Virginia-Maryland Regional College of Veterinary Medicine. Her research interests include nutritional support interventions for cancer and obesity as well as critical care nutrition including nutrients as related to oxidative stress disease. Research that she has been involved in has been published in the Journal of the American Veterinary Medical Association, Molecular Biology, Clinician’s Brief, Today’s Veterinary Practice, American Journal of Veterinary Research, and Veterinary Therapeutics among others. Dr Saker helped finalize the formulation of Canine Biologics’ first food component – our Chicken and Brown Rice Recipe and will provide nutritional expertise to future products.

Mr. Bennett holds a B.A. in Economics and an MBA, both from the University of Michigan. He has resided and worked in the U.S., Europe and Asia.
An expert in designing and implementing data-driven marketing planning systems, decision automation and predictive analytics, Tim helps companies make the shift to less costly and more effective new marketing technologies and to reliable measurement of marketing ROI that will increase the accountability of marketing staffs and align their efforts with the company's strategy.
Tim served as General Director - Brand Strategy and Research for General Motors for seven years where he guided the global decision-making of GM's most senior leaders regarding brand portfolio management, including market entry planning, divestitures and capital planning.

Dr. Hafeman has 14 years of hands on veterinary care experience specializing in oncology. He holds a PhD in Tumor Immunology. Dr. Hafeman guides Canine Biologics’ on-going research and product development efforts.

Dr. Dominique Gouty brings 25 years of business leadership experience in multi-national Pharmaceutical/Healthcare and Services industries, spanning R&D, clinical operations, animal healthcare, diagnostics, and manufacturing.
Dr. Gouty most recently served as the Chief Scientific Officer at BioAgilytix, a contract research laboratory. Over her tenure she participated in successfully bringing half of all the biologic drugs (including gene and cell therapies) to final approval by the FDA. Before this she led an international pharma division of a contract research laboratory specializing in small and large molecule services. Her strategic leadership role led to the building of several market-leading services companies in different locations around the world. Dr. Gouty also has 15 years of prior industry experience with Eli Lilly, J&J, and smaller biotech companies.
Dr. Gouty is a leading expert in novel therapeutic biologics, gene therapy, cell therapy, and biosimilars. She has written several books and over 150 published scientific papers covering areas of new drug development/healthcare, and she holds patents on drugs and technologies which have contributed to bringing multiple drugs to market.
Dr. Gouty has a deep and expert knowledge on the evolving regulations of the FDA, EMA, and other agencies. She has also served on boards in the health care service sector.